Daxor Corp (DXR) – Strategy, SWOT and Corporate Finance Report

Daxor Corp (DXR) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company

Key Highlights

Daxor Corp (Daxor) is a biotechnology company, which offers original medical equipment for medical personnel. The company manufactures blood volume analyzers. Its flagship product, BVA-100 blood volume analyzer is an instrument to measure human blood volume. The product is used in conjunction with Volumex, a diagnostic radiopharmaceutical containing iodinated I 131 albumins. It finds application in a range of medical and surgical conditions which includes congestive heart failure, intensive care unit medicine, critical care medicine, syncope, kidney failure, hypertension, renal failure, red blood cell abnormalities, hyponatremia and other conditions. The company offers its product to hospitals, clinics, and physicians. Daxor is headquartered in Oak Ridge, the US.

Scope

• Detailed information on Daxor Corp required for business and competitor intelligence needs

• A study of the major internal and external factors affecting Daxor Corp in the form of a SWOT analysis

• An in-depth view of the business model of Daxor Corp including a breakdown and examination of key business segments

• News about Daxor Corp, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of Daxor Corp and the factors that influence its strategies.

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess Daxor Corp as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on Daxor Corps business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Pacific Reproductive Center

Siemens Healthineers AG

Hema Care Corp.

Genetics & IVF Institute

California Cryobank

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Daxor Corp - Key Facts

Daxor Corp - Key Employees

Daxor Corp - Key Employee Biographies

Daxor Corp - Major Products and Services

Daxor Corp - History

Daxor Corp - Company Statement

Daxor Corp - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

Daxor Corp - Business Description

Daxor Corp - SWOT Analysis

SWOT Analysis - Overview

Daxor Corp - Strengths

Daxor Corp - Weaknesses

Daxor Corp - Opportunities

Daxor Corp - Threats

Daxor Corp - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Daxor Corp, Medical Equipment, Deals By Year, 2017 to YTD 2023

Daxor Corp, Medical Equipment, Deals By Type, 2017 to YTD 2023

Daxor Corp, Recent Deals Summary

Section 5 – Company’s Recent Developments

Jun 15, 2023: Daxor Accelerates Blood Volume Analysis Adoption with the Launch of ezBVA Lab Services

Mar 02, 2023: Daxor to Report Fiscal Year 2022 Financial Results on Wednesday, March 1, 2023 and Provide Corporate Update

Jan 19, 2023: Daxor Corporation Joins the Heart Failure Society of America (HFSA) as a Corporate Member

Jan 13, 2023: Daxor Corporation to exhibit at the Society for Critical Care Medicine 2023 Critical Care Congress

Sep 26, 2022: Daxor Corporation to Exhibit at the Annual Scientific Meeting of the Heart Failure Society of America

Sep 06, 2022: Daxor Corporation to Attend the H.C. Wainwright 24th Annual Global Investment Conference

Aug 24, 2022: Daxor to Report First Half 2022 Financial Results on Thursday, August 25, 2022, and Provide Corporate Update

Aug 24, 2022: Daxor Corp to Report First Half 2022 Financial Results on Thursday, August 25, 2022, and Provide Corporate Update

May 12, 2022: Daxor to Present at the H.C. Wainwright & Company Global Investment Conference

Mar 23, 2022: Daxor Corp to Participate in the Maxim Group 2022 Virtual Growth Conference

Section 6 – Appendix

Methodology

Ratio Definitions

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

Daxor Corp, Key Facts

Daxor Corp, Key Employees

Daxor Corp, Key Employee Biographies

Daxor Corp, Major Products and Services

Daxor Corp, History

Daxor Corp, Subsidiaries

Daxor Corp, Key Competitors

Daxor Corp, Ratios based on current share price

Daxor Corp, Annual Ratios

Daxor Corp, Annual Ratios (Cont…1)

Daxor Corp, Interim Ratios

Daxor Corp, Medical Equipment, Deals By Year, 2017 to YTD 2023

Daxor Corp, Medical Equipment, Deals By Type, 2017 to YTD 2023

Daxor Corp, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Daxor Corp, Performance Chart (2018 – 2022)

Daxor Corp, Ratio Charts

Daxor Corp, Medical Equipment, Deals By Year, 2017 to YTD 2023

Daxor Corp, Medical Equipment, Deals by Type, 2017 to YTD 2023

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports